Robin Roberts appears on Good Morning America in New York, Wednesday, Nov. 23, 2011. (AP Photo/Charles Sykes) On Monday, Good Morning America anchor Robin Roberts announced to viewers that she has ...

Researchers at Dresden University Hospital may have discovered a new therapeutic approach for treating myelodysplastic syndromes (MDS). In a recent study, the team headed by Prof. Manja Wobus and Dr.

Median duration of Complete Remission (CR) in treatment-naïve higher-risk myelodysplastic syndrome (HR-MDS) extended to 16.1 months with bexmarilimab + azacitidine Frontline HR-MDS treatment achieved ...

Luspatercept is emerging as a frontline option for lower-risk MDS patients, offering sustained transfusion independence with ...

MPNs involve overproduction of blood cells, while MDS results in poorly formed cells, affecting blood cell function and counts. Diagnosis requires blood tests, bone marrow biopsy, and genetic testing ...

Hemoglobin levels, transfusion independence, and low serum erythropoietin levels were all deemed to have a statistically significant relationship with erythropoiesis-stimulating agent (ESA) response.

What if a blood test could reveal the pace of our aging—and the diseases that may lie ahead? The labs of Profs. Liran Shlush and Amos Tanay at the Weizmann Institute of Science have been conducting in ...

BACKGROUND. Myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid neoplasms with variable clinical outcomes and an increased risk of progression to Acute Myeloid Leukemia (AML). Given ...

For patients with MDS who benefit from delaying transplants, it’s important to take care of their health while savoring their time before transplant. It’s important for patients with myelodysplastic ...